시장조사 보고서 : 세계의 근감소증 치료 시장예측 2021년-2026년

■ 영문 제목 : Global Sarcopenia Treatments Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02169 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 103 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 근감소증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (단백질 보충제, 칼슘 보충제, 기타)와 용도별 시장규모 (온라인 약국, 소매 약국) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 근감소증 치료 시장 점유율
- 지역별 근감소증 치료 시장규모
- 주요지역의 종류별 시장규모 (단백질 보충제, 칼슘 보충제, 기타)
- 주요지역의 용도별 시장규모 (온라인 약국, 소매 약국)
- 미주의 근감소증 치료 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 근감소증 치료 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 근감소증 치료 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 근감소증 치료 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 근감소증 치료 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Abbott Laboratories, Nestlé, Pfizer, Amway, By-health, Usana, A&Z Pharmaceutical, GlaxoSmithKline, Bayer, H&H, Blackmores, Zhendong Group
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Sarcopenia Treatments will have significant change from previous year. By the most conservative estimates of global Sarcopenia Treatments market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2583.9 million in 2020. Over the next five years the Sarcopenia Treatments market will register a 4.8% CAGR in terms of revenue, the global market size will reach US$ 3113.5 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Sarcopenia Treatments market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Protein Supplement
Calcium Supplement
Other
The proportion of protein supplement in 2018 is about 57%.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Online Pharmacies
Retail Pharmacies
The most of sarcopenia treatments is sales through retail pharmacies, and the market share of that is about 66% in 2018.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Nestlé
Pfizer
Amway
By-health
Usana
A&Z Pharmaceutical
GlaxoSmithKline
Bayer
H&H
Blackmores
Zhendong Group

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sarcopenia Treatments Market Size 2016-2026
2.1.2 Sarcopenia Treatments Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Sarcopenia Treatments Segment by Type
2.2.1 Protein Supplement
2.2.2 Protein Supplement
2.2.3 Other
2.3 Sarcopenia Treatments Market Size by Type
2.3.1 Global Sarcopenia Treatments Market Size CAGR by Type
2.3.2 Global Sarcopenia Treatments Market Size Market Share by Type (2016-2021)
2.4 Sarcopenia Treatments Segment by Application
2.4.1 Online Pharmacies
2.4.2 Retail Pharmacies
2.5 Sarcopenia Treatments Market Size by Application
2.5.1 Global Sarcopenia Treatments Market Size CAGR by Application
2.5.2 Global Sarcopenia Treatments Market Size Market Share by Application (2016-2021)

3 Sarcopenia Treatments Market Size by Players
3.1 Sarcopenia Treatments Market Size Market Share by Players
3.1.1 Global Sarcopenia Treatments Revenue by Players (2019-2021E)
3.1.2 Global Sarcopenia Treatments Revenue Market Share by Players (2019-2021E)
3.2 Global Sarcopenia Treatments Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Sarcopenia Treatments by Regions
4.1 Sarcopenia Treatments Market Size by Regions (2016-2021)
4.2 Americas Sarcopenia Treatments Market Size Growth (2016-2021)
4.3 APAC Sarcopenia Treatments Market Size Growth (2016-2021)
4.4 Europe Sarcopenia Treatments Market Size Growth (2016-2021)
4.5 Middle East & Africa Sarcopenia Treatments Market Size Growth (2016-2021)

5 Americas
5.1 Americas Sarcopenia Treatments Market Size by Country (2016-2021)
5.2 Americas Sarcopenia Treatments Market Size by Type (2016-2021)
5.3 Americas Sarcopenia Treatments Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Sarcopenia Treatments Market Size by Region (2016-2021)
6.2 APAC Sarcopenia Treatments Market Size by Type (2016-2021)
6.3 APAC Sarcopenia Treatments Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Sarcopenia Treatments by Country (2016-2021)
7.2 Europe Sarcopenia Treatments Market Size by Type (2016-2021)
7.3 Europe Sarcopenia Treatments Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Sarcopenia Treatments by Region (2016-2021)
8.2 Middle East & Africa Sarcopenia Treatments Market Size by Type (2016-2021)
8.3 Middle East & Africa Sarcopenia Treatments Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Sarcopenia Treatments Market Forecast
10.1 Global Sarcopenia Treatments Forecast by Regions (2021-2026)
10.1.1 Global Sarcopenia Treatments Forecast by Regions (2021-2026)
10.1.2 Americas Sarcopenia Treatments Forecast
10.1.3 APAC Sarcopenia Treatments Forecast
10.1.4 Europe Sarcopenia Treatments Forecast
10.1.5 Middle East & Africa Sarcopenia Treatments Forecast
10.2 Americas Sarcopenia Treatments Forecast by Countries (2021-2026)
10.2.1 United States Sarcopenia Treatments Market Forecast
10.2.2 Canada Sarcopenia Treatments Market Forecast
10.2.3 Mexico Sarcopenia Treatments Market Forecast
10.2.4 Brazil Sarcopenia Treatments Market Forecast
10.3 APAC Sarcopenia Treatments Forecast by Region (2021-2026)
10.3.1 China Sarcopenia Treatments Market Forecast
10.3.2 Japan Sarcopenia Treatments Market Forecast
10.3.3 Korea Sarcopenia Treatments Market Forecast
10.3.4 Southeast Asia Sarcopenia Treatments Market Forecast
10.3.5 India Sarcopenia Treatments Market Forecast
10.3.6 Australia Sarcopenia Treatments Market Forecast
10.4 Europe Sarcopenia Treatments Forecast by Country (2021-2026)
10.4.1 Germany Sarcopenia Treatments Market Forecast
10.4.2 France Sarcopenia Treatments Market Forecast
10.4.3 UK Sarcopenia Treatments Market Forecast
10.4.4 Italy Sarcopenia Treatments Market Forecast
10.4.5 Russia Sarcopenia Treatments Market Forecast
10.5 Middle East & Africa Sarcopenia Treatments Forecast by Region (2021-2026)
10.5.1 Egypt Sarcopenia Treatments Market Forecast
10.5.2 South Africa Sarcopenia Treatments Market Forecast
10.5.3 Israel Sarcopenia Treatments Market Forecast
10.5.4 Turkey Sarcopenia Treatments Market Forecast
10.5.5 GCC Countries Sarcopenia Treatments Market Forecast
10.6 Global Sarcopenia Treatments Forecast by Type (2021-2026)
10.7 Global Sarcopenia Treatments Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Sarcopenia Treatments Product Offered
11.1.3 Abbott Laboratories Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Nestlé
11.2.1 Nestlé Company Information
11.2.2 Nestlé Sarcopenia Treatments Product Offered
11.2.3 Nestlé Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Nestlé Main Business Overview
11.2.5 Nestlé Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Sarcopenia Treatments Product Offered
11.3.3 Pfizer Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Amway
11.4.1 Amway Company Information
11.4.2 Amway Sarcopenia Treatments Product Offered
11.4.3 Amway Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Amway Main Business Overview
11.4.5 Amway Latest Developments
11.5 By-health
11.5.1 By-health Company Information
11.5.2 By-health Sarcopenia Treatments Product Offered
11.5.3 By-health Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 By-health Main Business Overview
11.5.5 By-health Latest Developments
11.6 Usana
11.6.1 Usana Company Information
11.6.2 Usana Sarcopenia Treatments Product Offered
11.6.3 Usana Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Usana Main Business Overview
11.6.5 Usana Latest Developments
11.7 A&Z Pharmaceutical
11.7.1 A&Z Pharmaceutical Company Information
11.7.2 A&Z Pharmaceutical Sarcopenia Treatments Product Offered
11.7.3 A&Z Pharmaceutical Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 A&Z Pharmaceutical Main Business Overview
11.7.5 A&Z Pharmaceutical Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Sarcopenia Treatments Product Offered
11.8.3 GlaxoSmithKline Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Sarcopenia Treatments Product Offered
11.9.3 Bayer Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 H&H
11.10.1 H&H Company Information
11.10.2 H&H Sarcopenia Treatments Product Offered
11.10.3 H&H Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 H&H Main Business Overview
11.10.5 H&H Latest Developments
11. Blackmores
11.11.1 Blackmores Company Information
11.11.2 Blackmores Sarcopenia Treatments Product Offered
11.11.3 Blackmores Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Blackmores Main Business Overview
11.11.5 Blackmores Latest Developments
11.12 Zhendong Group
11.12.1 Zhendong Group Company Information
11.12.2 Zhendong Group Sarcopenia Treatments Product Offered
11.12.3 Zhendong Group Sarcopenia Treatments Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Zhendong Group Main Business Overview
11.12.5 Zhendong Group Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Sarcopenia Treatments Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Protein Supplement
Table 3. Major Players of Calcium Supplement
Table 4. Major Players of Other
Table 5. Sarcopenia Treatments Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Sarcopenia Treatments Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Sarcopenia Treatments Market Size Market Share by Type (2016-2021)
Table 8. Sarcopenia Treatments Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Sarcopenia Treatments Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Sarcopenia Treatments Market Size Market Share by Application (2016-2021)
Table 11. Global Sarcopenia Treatments Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Sarcopenia Treatments Revenue Market Share by Players (2019-2021E)
Table 13. Sarcopenia Treatments Key Players Head office and Products Offered
Table 14. Sarcopenia Treatments Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Sarcopenia Treatments Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Sarcopenia Treatments Market Size Market Share by Regions 2016-2021
Table 19. Americas Sarcopenia Treatments Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Sarcopenia Treatments Market Size Market Share by Country (2016-2021)
Table 21. Americas Sarcopenia Treatments Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Sarcopenia Treatments Market Size Market Share by Type (2016-2021)
Table 23. Americas Sarcopenia Treatments Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Sarcopenia Treatments Market Size Market Share by Application (2016-2021)
Table 25. APAC Sarcopenia Treatments Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Sarcopenia Treatments Market Size Market Share by Region (2016-2021)
Table 27. APAC Sarcopenia Treatments Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Sarcopenia Treatments Market Size Market Share by Type (2016-2021)
Table 29. APAC Sarcopenia Treatments Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Sarcopenia Treatments Market Size Market Share by Application (2016-2021)
Table 31. Europe Sarcopenia Treatments Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Sarcopenia Treatments Market Size Market Share by Country (2016-2021)
Table 33. Europe Sarcopenia Treatments Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Sarcopenia Treatments Market Size Market Share by Type (2016-2021)
Table 35. Europe Sarcopenia Treatments Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Sarcopenia Treatments Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Sarcopenia Treatments Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Sarcopenia Treatments Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Sarcopenia Treatments Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Sarcopenia Treatments Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Sarcopenia Treatments Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Sarcopenia Treatments Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Sarcopenia Treatments
Table 44. Key Application and Potential Industries of Sarcopenia Treatments
Table 45. Key Challenges of Sarcopenia Treatments
Table 46. Key Trends of Sarcopenia Treatments
Table 47. Global Sarcopenia Treatments Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Sarcopenia Treatments Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Sarcopenia Treatments Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Sarcopenia Treatments Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Sarcopenia Treatments Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Sarcopenia Treatments Market Size Market Share Forecast by Application (2021-2026)
Table 53. Abbott Laboratories Details, Company Type, Sarcopenia Treatments Area Served and Its Competitors
Table 54. Abbott Laboratories Sarcopenia Treatments Product Offered
Table 55. Abbott Laboratories Sarcopenia Treatments Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Abbott Laboratories Main Business
Table 57. Abbott Laboratories Latest Developments
Table 58. Nestlé Details, Company Type, Sarcopenia Treatments Area Served and Its Competitors
Table 59. Nestlé Sarcopenia Treatments Product Offered
Table 60. Nestlé Main Business
Table 61. Nestlé Sarcopenia Treatments Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Nestlé Latest Developments
Table 63. Pfizer Details, Company Type, Sarcopenia Treatments Area Served and Its Competitors
Table 64. Pfizer Sarcopenia Treatments Product Offered
Table 65. Pfizer Main Business
Table 66. Pfizer Sarcopenia Treatments Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Pfizer Latest Developments
Table 68. Amway Details, Company Type, Sarcopenia Treatments Area Served and Its Competitors
Table 69. Amway Sarcopenia Treatments Product Offered
Table 70. Amway Main Business
Table 71. Amway Sarcopenia Treatments Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Amway Latest Developments
Table 73. By-health Details, Company Type, Sarcopenia Treatments Area Served and Its Competitors
Table 74. By-health Sarcopenia Treatments Product Offered
Table 75. By-health Main Business
Table 76. By-health Sarcopenia Treatments Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. By-health Latest Developments
Table 78. Usana Details, Company Type, Sarcopenia Treatments Area Served and Its Competitors
Table 79. Usana Sarcopenia Treatments Product Offered
Table 80. Usana Main Business
Table 81. Usana Sarcopenia Treatments Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Usana Latest Developments
Table 83. A&Z Pharmaceutical Details, Company Type, Sarcopenia Treatments Area Served and Its Competitors
Table 84. A&Z Pharmaceutical Sarcopenia Treatments Product Offered
Table 85. A&Z Pharmaceutical Main Business
Table 86. A&Z Pharmaceutical Sarcopenia Treatments Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. A&Z Pharmaceutical Latest Developments
Table 88. GlaxoSmithKline Details, Company Type, Sarcopenia Treatments Area Served and Its Competitors
Table 89. GlaxoSmithKline Sarcopenia Treatments Product Offered
Table 90. GlaxoSmithKline Main Business
Table 91. GlaxoSmithKline Sarcopenia Treatments Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. GlaxoSmithKline Latest Developments
Table 93. Bayer Details, Company Type, Sarcopenia Treatments Area Served and Its Competitors
Table 94. Bayer Sarcopenia Treatments Product Offered
Table 95. Bayer Main Business
Table 96. Bayer Sarcopenia Treatments Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Bayer Latest Developments
Table 98. H&H Details, Company Type, Sarcopenia Treatments Area Served and Its Competitors
Table 99. H&H Sarcopenia Treatments Product Offered
Table 100. H&H Main Business
Table 101. H&H Sarcopenia Treatments Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. H&H Latest Developments
Table 103. Blackmores Details, Company Type, Sarcopenia Treatments Area Served and Its Competitors
Table 104. Blackmores Sarcopenia Treatments Product Offered
Table 105. Blackmores Sarcopenia Treatments Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Blackmores Main Business
Table 107. Blackmores Latest Developments
Table 108. Zhendong Group Details, Company Type, Sarcopenia Treatments Area Served and Its Competitors
Table 109. Zhendong Group Sarcopenia Treatments Product Offered
Table 110. Zhendong Group Main Business
Table 111. Zhendong Group Sarcopenia Treatments Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 112. Zhendong Group Latest Developments
List of Figures
Figure 1. Sarcopenia Treatments Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sarcopenia Treatments Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Sarcopenia Treatments Market Size Market Share by Type in 2020
Figure 7. Sarcopenia Treatments in Online Pharmacies
Figure 8. Global Sarcopenia Treatments Market: Online Pharmacies (2016-2021) & ($ Millions)
Figure 9. Sarcopenia Treatments in Retail Pharmacies
Figure 10. Global Sarcopenia Treatments Market: Retail Pharmacies (2016-2021) & ($ Millions)
Figure 11. Global Sarcopenia Treatments Market Size Market Share by Application in 2020
Figure 12. Global Sarcopenia Treatments Revenue Market Share by Player in 2020
Figure 13. Global Sarcopenia Treatments Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Sarcopenia Treatments Market Size 2016-2021 ($ Millions)
Figure 15. APAC Sarcopenia Treatments Market Size 2016-2021 ($ Millions)
Figure 16. Europe Sarcopenia Treatments Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Sarcopenia Treatments Market Size 2016-2021 ($ Millions)
Figure 18. Americas Sarcopenia Treatments Market Size Market Share by Country in 2020
Figure 19. Americas Sarcopenia Treatments Market Size Market Share by Type in 2020
Figure 20. Americas Sarcopenia Treatments Market Size Market Share by Application in 2020
Figure 21. United States Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Sarcopenia Treatments Market Size Market Share by Regions in 2020
Figure 25. APAC Sarcopenia Treatments Market Size Market Share by Type in 2020
Figure 26. APAC Sarcopenia Treatments Market Size Market Share by Application in 2020
Figure 27. China Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Sarcopenia Treatments Market Size Market Share by Country in 2020
Figure 34. Europe Sarcopenia Treatments Market Size Market Share by Type in 2020
Figure 35. Europe Sarcopenia Treatments Market Size Market Share by Application in 2020
Figure 36. Germany Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Sarcopenia Treatments Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Sarcopenia Treatments Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Sarcopenia Treatments Market Size Market Share by Application in 2020
Figure 44. Egypt Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country Sarcopenia Treatments Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 50. APAC Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 51. Europe Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 53. United States Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 54. Canada Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 57. China Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 58. Japan Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 59. Korea Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 61. India Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 62. Australia Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 63. Germany Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 64. France Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 65. UK Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 66. Italy Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 67. Russia Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 68. Spain Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 71. Israel Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Sarcopenia Treatments Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country Sarcopenia Treatments Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 근감소증 치료 시장예측 2021년-2026년] (코드 : LPI-2201K02169) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 근감소증 치료 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 주사 치료 시장예측 2021년-2026년
LPI-2201K02295 / LP Information / 2021년 12월 / 본 조사보고서는 주사 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Rosacea Treatments will have significant change from previous year. By the most conservative estimates of global Rosacea Treatments market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 13 million in 2020. Over...

세계의 탈모 및 성장 트리트먼트 제품 시장예측 2021년-2026년
LPI-2201K01596 / LP Information / 2021년 12월 / 본 조사보고서는 탈모 및 성장 트리트먼트 제품의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일,...According to this latest study, the 2021 growth of Hair Loss&Growth Treatments and Products will have significant change from previous year. By the most conservative estimates of global Hair Loss&Growth Treatments and Products market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...

세계의 석재 발수 처리 시장예측 2021년-2026년
LPI-2201K03583 / LP Information / 2021년 12월 / 본 조사보고서는 석재 발수 처리의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Stone Water Repellent Treatments will have significant change from previous year. By the most conservative estimates of global Stone Water Repellent Treatments market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 148.2...

세계의 비침습적 바디 쉐이핑 시장예측 2021년-2026년
LPI-2201K02408 / LP Information / 2021년 12월 / 본 조사보고서는 비침습적 바디 쉐이핑의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Non-Invasive Body Shaping will have significant change from previous year. By the most conservative estimates of global Non-Invasive Body Shaping market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in...

세계의 비수술 신체 조형 시장예측 2021년-2026년
LPI-2201K02414 / LP Information / 2021년 12월 / 본 조사보고서는 비수술 신체 조형의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Non-Surgical Body Sculpting will have significant change from previous year. By the most conservative estimates of global Non-Surgical Body Sculpting market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 다발성 골수종 치료제 시장예측 2021년-2026년
LPI-2201K02234 / LP Information / 2021년 12월 / 본 조사보고서는 다발성 골수종 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Multiple Myeloma Therapeutics will have significant change from previous year. By the most conservative estimates of global Multiple Myeloma Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 26680 million in...

세계의 사이즈 배제 크로마토그래피 컬럼 시장예측 2021년-2026년
LPI-2201K02582 / LP Information / 2021년 12월 / 본 조사보고서는 사이즈 배제 크로마토그래피 컬럼의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Size Exclusion Chromatography Column will have significant change from previous year. By the most conservative estimates of global Size Exclusion Chromatography Column market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...